![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Study of ATS 3f Aortic Bioprosthesis
FDA Approves Study of ATS 3f Aortic Bioprosthesis
August 27, 2009
ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced that the FDA has approved a landmark clinical study in which cardiac surgeons will implant the ATS 3f Aortic Bioprosthesis in a younger aortic valve replacement patient population that has not been previously studied in a controlled and scientific manner.
CNBC
CNBC
Upcoming Events
-
21Oct